The Alliance for Plasma Therapies received its 501(c)(3) nonprofit status from the Internal Revenue Service inApril 2009.
Octapharma AG recently submitted its biological license application for Octagam 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration.
College students with hemophilia or a related bleeding disorder are eligible to apply forthe Eric Dostie Memorial College Scholarship.
The Flu-Free and a Mom-to-Be consumer education campaign received the 2009 Immunization Excellence Award for Best Corporate Campaign at the National Influenza Vaccine Summit’s annual meeting on June 29.
Public health authorities are urging individuals to get the pneumonia vaccine to reduce hospitalizations and deaths associated with the virus.
In 2010, monthly premiums for Medicare beneficiaries who are enrolled in Part D stand-alone prescription drug plans will rise 11 percent on average.
The U.S. Food and Drug Administration granted accelerated approval for Novartis AG’s Agriflu to prevent disease caused by influenza virus subtypes A and B in adults ages 18 years and older.
Merck & Co., Inc. has entered into an exclusive agreement with CSL Biotherapies to market and distribute Afluria, CSL’s seasonal influenza vaccine in the U.S.
More than 50 percent of healthcare executives say lapses in the supply chain prevent their companies to respond quickly to pandemics.